在野生型动物模型中诱导针对 HIV 包膜三聚体 V2 顶点的中和抗体。
Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.
机构信息
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Division of Infection and Immunity, Faculty of Medical Science, University College London, London WC1E 6BT, UK.
出版信息
Cell Rep. 2017 Oct 3;21(1):222-235. doi: 10.1016/j.celrep.2017.09.024.
Recent efforts toward HIV vaccine development include the design of immunogens that can engage B cell receptors with the potential to affinity mature into broadly neutralizing antibodies (bnAbs). V2-apex bnAbs, which bind a protein-glycan region on HIV envelope glycoprotein (Env) trimer, are among the most broad and potent described. We show here that a rare "glycan hole" at the V2 apex is enriched in HIV isolates neutralized by inferred precursors of prototype V2-apex bnAbs. To investigate whether this feature could focus neutralizing responses onto the apex bnAb region, we immunized wild-type rabbits with soluble trimers adapted from these Envs. Potent autologous tier 2 neutralizing responses targeting basic residues in strand C of the V2 region, which forms the core epitope for V2-apex bnAbs, were observed. Neutralizing monoclonal antibodies (mAbs) derived from these animals display features promising for subsequent broadening of the response.
最近在 HIV 疫苗研发方面的努力包括设计能够与 B 细胞受体结合的免疫原,这些免疫原有可能亲和力成熟为广泛中和抗体 (bnAb)。V2-顶点 bnAb 是结合 HIV 包膜糖蛋白 (Env) 三聚体上蛋白糖基区域的最广泛和最有效的 bnAb 之一。我们在这里表明,在被推断为原型 V2-顶点 bnAb 前体中和的 HIV 分离株中,V2 顶点的罕见“聚糖孔”丰富。为了研究这种特征是否可以将中和反应集中在顶点 bnAb 区域,我们用来自这些Env 的可溶性三聚体免疫野生型兔子。观察到针对 V2 区域 C 链碱性残基的强效自体 2 级中和反应,这些残基形成 V2-顶点 bnAb 的核心表位。从这些动物中衍生的中和单克隆抗体 (mAb) 具有随后扩大反应的前景。